Notice is hereby given that the 110th Annual General Meeting of Pharmaceutical Defence Limited will be a hybrid meeting, both in person at Suite 3, Level 34 North Tower, 80 Collins Street, Melbourne 3000 and online via Microsoft Teams, on Thursday, the 20th of October 2022 at 11:00am AEDT when the attendance of members is requested.
Ordinary Business
1. To confirm the Minutes of the preceding Annual General Meeting which took place on the 21st of October 2021.
2. To receive and consider and deal with the Financial Statements and Statutory Reports for the year ended 30th June 2022.
3. To confirm the election of Directors duly elected in accordance with Clause 17 of the Constitution.
3.1 Paul Naismith from the State of Victoria retires in accordance with Clause 17.3 and being eligible has offered himself for re-election.
3.2 Joseph O’Malley from the State of Tasmania retires in accordance with Clause 17.3 and being eligible has offered himself for re-election.
4. To fix the remuneration of the Directors.
Other Business
To transact any business which, under the Corporations Act 2001 or the Constitution, is required to be transacted at an Annual General Meeting.
Virtual Participation
If you would like to attend the meeting online, please contact Julie.Michel@pdl.org.au so that we can send you a meeting invitation.
Proxies
An eligible member who is unable to attend the meeting is entitled to appoint a proxy to attend and vote. That person need not be a member of the Company but should be a natural person over the age of 18 years. Proxy forms may be downloaded here.
Completed, signed Proxy forms must be lodged at the Registered Office of the Company by 11.00am Monday, 17th October 2022. Proxy forms to be emailed to Julie.Michel@pdl.org.au or the original to be mailed to Suite 3, Level 34 North Tower, 80 Collins Street, Melbourne 3000.
Annual Report
The PDL 2022 Annual Report can be accessed via member login to the portal. Please be advised this will only be provided in hard copy upon written/emailed request.
Yours faithfully,
Glen Oliver
Company Secretary
Pharmaceutical Defence Limited
